Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6Pain 3Burns 2Breakthrough Pain 2Anemia, Sickle Cell 2Agnosia 2Pain, Postoperative 1Pain, Intractable 1Lung Neoplasms 1Intrathecal Dexmedetomidine 1Dyspnea, Paroxysmal 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Bone Metastases 1

Interventions

ziconotide 1resiniferatoxin 1Midazolam 1Fentanyl 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pain, Intractable × Fentanyl × Clear all
NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Janssen Pharmaceutical K.K.

Phase 2 Completed
87 enrolled

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡